covid
Buscar en
Endocrinología y Nutrición (English Edition)
Toda la web
Inicio Endocrinología y Nutrición (English Edition) Interns’ viewpoints and knowledge about management of hyperglycemia in the hos...
Journal Information
Vol. 59. Issue 7.
Pages 423-428 (August - September 2012)
Visits
2615
Vol. 59. Issue 7.
Pages 423-428 (August - September 2012)
Original article
Full text access
Interns’ viewpoints and knowledge about management of hyperglycemia in the hospital setting
Tratamiento de la hiperglucemia en el hospital. Impresiones y conocimientos del médico residente
Visits
2615
Betina Biagetti
Corresponding author
bbiagetti@vhebron.net

Corresponding author.
, Andrea Ciudin, Marina Portela, Belen Dalama, Jordi Mesa
Servicio de Endocrinología, Hospital Universitari Vall d’Hebron, Barcelona, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (2)
Table 1. Opinions of resident physicians about hyperglycemia in the hospital setting before and after the training sessions.
Table 2. Barriers perceived by residents for the adequate management of hyperglycemia in the hospital setting.
Show moreShow less
Additional material (1)
Abstract
Background and objective

In many hospitals, adequate glycemic control is not achieved despite implementation of new insulin therapy protocols. Our aim was to assess resident physician’ attitudes toward inpatient hyperglycemia, barriers to achieve optimum control, and the impact on them of an insulin training program.

Material and methods

A questionnaire was used to assess understanding and standard management of hyperglycemia before and six months after implementation of an inpatient insulin treatment program.

Results

Twenty-five interns completed the questionnaire. Glycemic control was considered “very important” in all admission situations, but was only considered “very important” in conventional hospitalization by 36% of interns. Most of these felt “comfortable” using sliding scales, but not with the basal/bolus regimen, which was the least commonly used. Perception of number of well-controlled patients and comfort and use of basal/bolus therapy increased at six months, but use of “sliding scales” remained high. The greatest difficulty reported for adequate management of hyperglycemia was the lack of knowledge.

Conclusions

Most residents are aware of the importance of adequate glycemic control, but cannot achieve it because of inadequate knowledge. The insulin training program led to an improved perception and applicability of basal-bolus insulin regimens. However, despite all efforts, use of sliding scales remains high. Training programs should emphasize management of hyperglycemia.

Keywords:
Diabetes
Hospital
Inpatient hyperglycemia
Interns
Medical education
Hyperglycemia
Resumen
Antecedentes y objetivo

En muchos hospitales se han instaurado nuevos protocolos de insulinoterapia, a pesar de lo cual, no se logra un adecuado control. Evaluamos mediante una encuesta, la percepción de los médicos residentes ante la hiperglucemia, determinamos las barreras para obtener un óptimo control, y el impacto en las mismas de un programa de insulinización.

Material y métodos

Se aplicó un cuestionario, que valoraba el grado de conocimiento y la práctica habitual ante la hiperglucemia, antes y a los 6 meses de la implantación de un protocolo de insulinoterapia intrahospitalario.

Resultados

Completaron el cuestionario 25 residentes. El control glucémico se consideró «muy importante» en todas las situaciones de ingreso; sin embargo, en la hospitalización convencional solo lo consideró el 36%. La mayor parte se sentían «cómodos» utilizando la pauta de «solo insulina rápida», que fue la más empleada, pero no con la pauta basal/bolo que era «poco/nada» utilizada. A los 6 meses, aumentó la percepción del número de pacientes bien controlados, el bienestar y utilización de las pautas basal/bolo, aunque el empleo de «solo insulina rápida» se mantuvo. La mayor dificultad referida para un adecuado manejo de la hiperglucemia fue la falta de conocimientos.

Conclusiones

Los facultativos residentes conocen la importancia de un adecuado control, pero la falta de conocimientos impide obtenerlo. El programa formativo y la protocolización conllevaron una mejoría en la percepción y aplicabilidad de las pautas intensificadas. Sin embargo, a pesar del esfuerzo, sigue siendo elevado el empleo de pautas basadas exclusivamente de insulina rápida. En el programa formativo de los residentes debería destacarse el majo de la hiperglucemia.

Palabras clave:
Diabetes
Hospitalización
Hiperglucemia en hospitalizados
Residentes
Educación médica
Hiperglucemia
Full Text
Introduction

Poor glycemic control in hospitalized diabetic patients is associated with increased morbidity and mortality and a resultant increase in healthcare costs.1–5 While 10 years ago hyperglycemia was ignored and there were no guidelines concerning its treatment, there is now overwhelming evidence showing the harmful effects of both hyperglycemia6–10 and hypoglycemia11 and the benefits of basal-bolus schemes over schemes using rapid-acting insulin alone (sliding scales).12,13 In addition, different management guidelines recommending different goals have been published.14–20

Hospitals have gradually implemented insulin administration protocols and different approaches regarding the training of physicians in charge of patients at the different hospitalization units. However, despite all efforts, adequate control is difficult to achieve, especially in big hospitals,21–24 in part because we do not know the obstacles that are preventing the application of protocols and, thus, the achievement of adequate glycemic control.24,25

In our hospital, the team responsible for disseminating the importance of the management of diabetes in the hospital setting and for modifying the standard treatment schemes detected some resistance to change in resident physicians, who also wanted additional information. The purpose of this study was therefore to assess the perception of hyperglycemia in hospitalized patients by resident physicians, and to ascertain both the barriers to achieving optimum glycemic control and the impact on them of an insulin administration protocol used in a city-based teaching hospital.

Materials and methods

The study was conducted on 25 resident physicians at a teaching hospital in Barcelona. The residents were sequentially selected from the emergency on-call duty program, and all residents who volunteered to participate were enrolled. The residents belonged to different medical specialties, internal medicine, and family medicine. They were all in charge of inpatients and performed on-call duties in their respective hospital wards and in the emergency room. Residents in endocrinology and nutrition were excluded because they have a specific training program.

The study was conducted in compliance with the ethical principles of the Declaration of Helsinki and Good Clinical Practice guidelines, and was approved by the ethical and clinical research committee of the hospital.

A questionnaire was administered during 2009 and 2010, before and six months after the implementation at the hospital of an insulin administration protocol for stable patients admitted to hospital wards, for which training and sensitization sessions on the subject for healthcare staff, both physicians and nurses, were initially held. These sessions were followed by a more practical second phase concerned with the application of insulin schemes which was divided into two clinical sessions.

Description of the questionnaire

The questionnaire, available online as an annex, was anonymous and adapted from the Cook et al. questionnaire.26 It focused on the different aspects of hyperglycemia in inpatients and consisted of the following sections:

  • 1.

    The prevalence, significance, and degree of glycemic control in inpatients.

  • 2.

    The control goals in the different admission situations.

  • 3.

    Familiarity and comfort with the different treatment schemes.

  • 4.

    Personal routine clinical practice.

  • 5.

    The obstacles preventing good glycemic control.

The glycemic control goals considered as acceptable (<126mg/dL after fasting and all controls <180mg/dL)16 were those established in the most recent recommendations of the American Diabetes Association and the Spanish Diabetes Association.17,20

SPSS 11.5 software was used for data analysis, and the group distribution of responses was examined. Quantitative variables are given as absolute values or percentages. Differences between subgroups were assessed using a Chi-square test. A value of p<0.05 was considered statistically significant. The obstacles to achieving adequate glycemic control reported by the surveyed residents were also listed in decreasing order of frequency.

Results

Fifty anonymous questionnaires completed by the 25 resident physicians surveyed before and six months after the implementation of the protocol and the training sessions were analyzed. Residents were in the following departments: 32% in internal medicine (n=8), 20% in family medicine (n=5), and 48% in the remaining medical departments (n=12).

Prevalence, significance, and degree of glycemic control in inpatients

When asked how many patients experienced hyperglycemia during their stay at their respective units, 18% of residents answered 21–40% of their patients, while 41% thought that hyperglycemia occurred in 41–60%, and 23% that 61–80% of their patients experienced hyperglycemia. Eighteen percent of residents did not know the answer, and no residents thought that hyperglycemia occurred in less than 20% of their patients.

As regards the significance of glycemic control, most of the residents surveyed thought that it was “quite” or “very important” (Table 1). Glycemic control was considered to be “very important” in critical patients by 63% and in pregnant women by 87%, while in general wards it was considered very important by only 36%.

Table 1.

Opinions of resident physicians about hyperglycemia in the hospital setting before and after the training sessions.

Category  Response
Importance of treating hyperglycemia  Very importantQuite importantSomewhat importantI do not knowp 
   
Intensive care unit  62  63  19  28  18  n.s 
General ward  36  64  54  36  10  <0.0001 
Perioperative period  55  73  40  27  n.s. 
Pregnant women  87  90  13  10  n.s. 
Proportion of well-controlled patients  <20%21-50>50%I do not knowp 
% of responses  28.5  48.5  45.5  10  54.5  13  <0.001 
Glucose control goal, mg/dL  80–11080–126126–180I do not knowp 
Intensive care unit  32  37  36  28  23  35  n.s 
General ward  14  37  72  47  16  <0.0001 
Perioperative period  27  27  55  63  10  14  n.s. 
Grade of comfort with treatment  Very comfortableQuite comfortableSomewhat comfortableNot very comfortable/uncomfortablep 
Treating hyperglycemia  13  36  29  40  19  24  59  <0.0001 
Using SC insulin  37  72  19  10  40  <0.0001 
Using insulin pumps  12  14  18  22  55  n.s. 
Familiarity with treatment  Very accustomedQuite accustomedSomewhat accustomedA little/not accustomedp 
“Rapid-acting insulin alone” scheme  40  37  22  27  19  18  19  18  n.s. 
Basal/bolus insulin therapy  19  36  86  45  <0.0001 
Intravenous insulin therapy  18  27  76  63  n.s. 
Standard clinical practice  Very oftenQuite oftenNot oftenLittle/not at allp 
“Rapid-acting insulin alone” scheme  3727  27  28  28  24  17  11  28  <0.0001 
Basal/bolus insulin therapy  846  46  18  27  10  10  62  17  <0.0001 
Intravenous insulin therapy  537  27  53  55  n.s. 

Data given as percentage of total responses (n=25), SC: subcutaneous. B, before; A, after; n.s., not significant.

After the implementation of the protocol and the training sessions, the proportion of residents who considered control at conventional wards as “very important” significantly increased from 36% to 54%. In addition, 100% of residents surveyed assessed glycemic as “very” or “quite important”, and no significant differences in the significance of control were detected in any admission situations after the training sessions.

As regards the proportion of patients adequately controlled during admission (Table 1), 77% of the residents surveyed said that control was achieved in less than half the cases. After the implementation of the program, 54% of residents thought that control had been achieved in most of them.

Glycemic control goals

When asked about the control goals in the different units and conditions during admission (Table 1), most residents surveyed (68%) answered that in intensive care units the glycemic goal should range from 80 to 126mg/dL, while 23% named values ranging from 126 to 180mg/dL, and 9% did not know. In general wards, 14% considered glucose levels ranging from 80 to 110mg/dL and 72% values ranging from 80 to 126mg/dL to be adequate, while 4% did not know. In surgical units, 82% reported blood glucose levels less than 126mg/dL as the desirable goal, and 14% did not know. After the program, the most striking change in glycemic goal occurred in general wards, where the proportion of residents who considered a strict glucose control (80–126mg/dL) as the most adequate response more than doubled, from 14% to 37% (p<0.05). No change was seen in responses regarding patients admitted to intensive care units and in the perioperative period.

Familiarity and comfort with treatments

When asked if they felt comfortable when treating hyperglycemia, 59% of residents answered that they felt “not very comfortable/uncomfortable”. After protocol implementation, however, 76% felt “quite or very comfortable” and none felt “not very comfortable/uncomfortable” (p<0.05) (Table 1).

As regards the different forms of insulin administration, most of the physicians surveyed were “very accustomed” to using insulin schemes with “rapid-acting insulin alone” and 86% were “a little/not accustomed” to the basal/bolus scheme. After six months, significant changes were only seen in the use of basal/bolus insulin therapy, to which 55% of residents (p<0.001) were “a little or quite accustomed”.

Standard clinical practice

When asked about the schemes routinely used by them, 67% reported that they used “very often” or “quite often” the “rapid-acting insulin alone” scheme, and 62% used “little/not at all” basal/bolus insulin therapy. After six months, 73% used basal/bolus insulin therapy “very or quite often”. However, the “rapid-acting insulin alone” scheme continued to be routinely used by more than half the residents (55%). The use of intravenous insulin therapy did not change after the program.

Barriers to achieving adequate control

As regards the barriers preventing the achievement of adequate control (Table 2), a number of items were listed and several responses could be given to each item in order of priority. No option was ignored by the residents, and the three options most commonly selected were: “Understanding and switching between the different insulin types”, “Understanding of treatment adjustment”, and “Ignoring when to start treatment”; moreover, only 5% of the residents surveyed answered “hyperglycemia is not a priority” and “I am limited by the risk of hypoglycemia”.

Table 2.

Barriers perceived by residents for the adequate management of hyperglycemia in the hospital setting.

  Number of responses 
Understanding and switching between the different types of insulin and their dosage forms  17  68 
Understanding the adjustment of insulin schemes  14  58 
Understanding when insulin therapy should be started  12  47 
The identification of the best option for treating hyperglycemia  31 
Knowledge of the guidelines for treating hyperglycemia  21 
The risk of inducing hypoglycemia 
The treatment of hyperglycemia is not a priority for me 
None, I have no problem in diabetes management 
Discussion

Glycemic control of patients admitted to hospital has become increasingly relevant in recent years, and control goals have been established.19 Despite these recommendations, basal/bolus insulin schemes are difficult to implement in many hospitals due to lack of information, training, or even the routine use of new algorithms, among other reasons.

Insulin is the treatment recommended for patients admitted to hospital for some time, and in recent years the marketing of different insulin analogues has promoted the use of the more physiological and standardized basal/bolus schemes to the detriment of schemes based on rapid-acting insulin alone. These advances have led to a proliferation of algorithms of both subcutaneous and intravenous insulin therapy, and different options, most of them effective, are available. The selection of the best alternative and the adjustment of the different schemes has somewhat complicated the management of admitted diabetic patients and requires an additional effort in the training of healthcare staff for diabetes treatment.

Our results agree with those reported in previous studies.25–28 However, no study comparing changes in attitude both before and after the implementation of a training program specifically for residents was available at the time of writing the manuscript.

In our hospital, the resident physicians thought that the treatment of diabetes was a significant part of their healthcare activity, had an exaggerated perception of the prevalence of hyperglycemia in hospitalized patients, as 64% answered that more than 40% of their patients were diabetics, and moreover, thought that these patients were usually inadequately controlled. This latter opinion had substantially changed by the end of the program and after the implementation of the insulin therapy protocol. The residents also considered glycemic control in the different hospitalization units important, particularly in intensive care units and in pregnant women, although it appeared to be less relevant and the normoglycemic goal was more flexible if the patient was admitted to a general ward. This perception had also changed by the end of the program, when the residents were more aware of the significance of adequate control during hospital admission.

Most residents did not feel comfortable with the treatment of hyperglycemia. This attitude had clearly changed by the end of the program, when residents felt more comfortable with basal/bolus schemes, maybe because the unification of the criteria had decreased their feelings of uncertainty regarding treatment.

Although their opinion about the advantages and use of basal/bolus insulin schemes significantly improved, a high number of residents continued to use schemes based on rapid-acting insulin alone. This may partly be explained by so-called “therapeutic inertia”, but it is also possible that our training program was not intensive enough or that there were difficulties in understanding or in the electronic prescription of the new algorithms. We agree in this regard with Kirk and Oldham,29 who suggested that pharmacy departments should be implicated in these programs to promote the basal/bolus scheme and to facilitate the use of current insulin therapy protocols.

Finally, among the limitations preventing adequate control, most of the residents surveyed reported aspects related to inadequate understanding of treatments, partly due to the increased use of insulin analogues (new insulins) without adequate training. Twenty-one percent of residents cited “ignorance of guidelines” as an obstacle and, surprisingly, only 5% said that they felt limited by “fear of hypoglycemia”, although this finding agrees with prior studies.25,26

The main limitation of this study was its small sample size, which prevented comparison between the different specialties of the residents surveyed. An additional limitation was that surgical specialties were not included because we felt that these required a specific study due to the differences in the training programs of the various medical specialties. Results should not be extrapolated to the non-resident medical staff because the questionnaire was designed for training staff, although it could be used in the future for all other physicians provided some small changes were made first.

In any case, this study clearly showed that some therapeutic inertia exists, because despite the resources used and the effort made, the “rapid-acting insulin alone” scheme continued to be routinely used by 55% of residents. It also demonstrated a lack of familiarity by many resident physicians with the recommendations and procedures recommended for the control of hyperglycemia during admission, despite its high prevalence. It would therefore be convenient to include in the early stages of the training programs for the different specialties a section on the hospital management of diabetes mellitus and hyperglycemic decompensation.28

Conflicts of interest

The authors state that they have no conflicts of interest.

Appendix A
Supplementary data

The following are the supplementary data to this article:

References
[1]
G.E. Umpierrez, S.D. Isaacs, N. Bazargan, X. You, L.M. Thaler, A.E. Kitabchi.
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.
J Clin Endocrinol Metab, 87 (2002), pp. 978-982
[2]
J. Oliva, F. Lobo, B. Molina, S. Monereo.
Direct health care costs of diabetic patients in Spain.
Diabetes Care, 27 (2004), pp. 2616-2621
[3]
M. Mata, F. Antoñanzas, M. Tafalla, P. Sanz.
The cost of type 2 diabetes in Spain: the CODE-2 study.
Gac Sanit, 16 (2002), pp. 511-520
[4]
C.L. Morgan, J.R. Peters, S. Dixon, C.J. Currie.
Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region.
Diabet Med, 27 (2010), pp. 1066-1073
[5]
A. López-de-Andrés, P. Carrasco-Garrido, J. Esteban-Hernández, A. Gil-de-Miguel, R. Jiménez-García.
Characteristics and hospitalization costs of patients with diabetes in Spain.
Diabetes Res Clin Pract, 89 (2010), pp. e2-e4
[6]
K. Malmberg.
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group.
BMJ, 314 (1997), pp. 1512-1515
[7]
K. Malmberg, A. Norhammar, H. Wedel, L. Rydén.
Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.
Circulation, 99 (1999), pp. 2626-2632
[8]
G. Van den Berghe, A. Wilmer, G. Hermans, W. Meersseman, P.J. Wouters, I. Milants, et al.
Intensive insulin therapy in the medical ICU.
N Engl J Med, 354 (2006), pp. 449-461
[9]
E.H. Baker, C.H. Janaway, B.J. Philips, A.L. Brennan, D.L. Baines, D.M. Wood, et al.
Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease.
Thorax, 61 (2006), pp. 284-289
[10]
F.A. McAlister, S.R. Majumdar, S. Blitz, B.H. Rowe, J. Romney, T.J. Marrie.
The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia.
Diabetes Care, 28 (2005), pp. 810-815
[11]
S. Finfer, D.R. Chittock, S.Y.-S. Su, D. Blair, D. Foster, V. Dhingra, et al.
Intensive versus conventional glucose control in critically ill patients.
N Engl J Med, 360 (2009), pp. 1283-1297
[12]
G.E. Umpierrez, D. Smiley, A. Zisman, L.M. Prieto, A. Palacio, M. Ceron, et al.
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
Diabetes Care, 30 (2007), pp. 2181-2186
[13]
T. Becker, A. Moldoveanu, T. Cukierman, H.C. Gerstein.
Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia.
Diabetes Res Clin Pract, 78 (2007), pp. 392-397
[14]
A.J. Garber, E.S. Moghissi, E.D Bransome Jr., N.G. Clark, S. Clement, R.H. Cobin, et al.
American College of Endocrinology position statement on inpatient diabetes and metabolic control.
Endocr Pract, 10 (2004), pp. 77-82
[15]
ACE/ADA Task Force on Inpatient Diabetes.
American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control.
Diabetes Care, 29 (2006), pp. 1955-1962
[16]
American Diabetes Association.
Standards of medical care in diabetes – 2008.
Diabetes Care, 31 (2008), pp. S12-S54
[17]
E.S. Moghissi, M.T. Korytkowski, M. DiNardo, D. Einhorn, R. Hellman, I.B. Hirsch, et al.
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.
Diabetes Care, 32 (2009), pp. 1119-1131
[18]
A. Pérez Pérez, P. Conthe Gutiérrez, M. Aguilar Diosdado, V. Bertomeu Martínez, P. Galdos Anuncibay, G. García de Casasola, et al.
Tratamiento de la hiperglicemia en el hospital.
Med Clin (Barc), 132 (2009), pp. 465-475
[19]
American Diabetes Association.
Executive summary: standards of medical care in diabetes – 2012.
Diabetes Care, 35 (2012), pp. S4-S10
[20]
G.E. Umpierrez, R. Hellman, M.T. Korytkowski, M. Kosiborod, G.A. Maynard, V.M. Montori, et al.
Management of hyperglycemia in hospitalized patients in non-critical care setting: An endocrine society clinical practice guideline.
J Clin Endocrinol Metab, 97 (2012), pp. 16-38
[21]
J.B. Boord, R.A. Greevy, S.S. Braithwaite, P.C. Arnold, P.M. Selig, H. Brake, et al.
Evaluation of hospital glycemic control at US academic medical centers.
J Hosp Med, 4 (2009), pp. 35-44
[22]
J.L. Schnipper, E.E. Barsky, S. Shaykevich, G. Fitzmaurice, M.L. Pendergrass.
Inpatient management of diabetes and hyperglycemia among general medicine patients at a large teaching hospital.
J Hosp Med, 1 (2006), pp. 145-150
[23]
D.J. Wexler, J.B. Meigs, E. Cagliero, D.M. Nathan, R.W. Grant.
Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals.
Diabetes Care, 30 (2007), pp. 367-369
[24]
M. Botella, J.A. Rubio, J.C. Percovich, E. Platero, C. Tasende, J. Álvarez.
Control glucémico en pacientes hospitalizados no críticos.
Endocrinol Nutr, 58 (2011), pp. 536-540
[25]
C.B. Cook, K.A. Jameson, Z.C. Hartsell, M.E. Boyle, B.J. Leonhardi, M. Farquhar-Snow, et al.
Beliefs about hospital diabetes and perceived barriers to glucose management among inpatient midlevel practitioners.
Diabetes Educ, 34 (2008), pp. 75-83
[26]
C.B. Cook, R.S. Zimmerman, S.M. Gauthier, J.C. Castro, K.A. Jameson, S.D. Littman, et al.
Understanding and improving management of inpatient diabetes mellitus: the Mayo Clinic Arizona experience.
J Diabetes Sci Technol, 2 (2008), pp. 925-931
[27]
C.B. Cook, D.A. McNaughton, C.M. Braddy, K.A. Jameson, L.R. Roust, S.A. Smith, et al.
Management of inpatient hyperglycemia: assessing perceptions and barriers to care among resident physicians.
Endocr Pract, 13 (2007), pp. 117-124
[28]
A. Lomas, J.J. ALfaro, C. Lamas, A. Hernández, L. López, J.J. Lozano, et al.
Percepción sobre el manejo de la diabetes mellitus en el paciente hospitalizado entre los médicos residentes de un hospital general universitario.
Endocrinol Nutr, 56 (2009),
[29]
J.K. Kirk, E.C. Oldham.
Hyperglycemia management using insulin in the acute care setting: therapies and strategies for care in the non-critically ill patient.
Ann Pharmacother, 44 (2010), pp. 1222-1230

Please cite this article as: Biagetti B, et al. Tratamiento de la hiperglucemia en el hospital. Impresiones y conocimientos del médico residente. Endocrinol Nutr. 2012. 2012;59(7):423-8.

Copyright © 2012. SEEN
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos